Big Pharma to settle birth defect claims related to antidepressant Paxil

GlaxoSmithKline has agreed to settle yet another big group of product-liability lawsuits involving one of its popular meds. The latest deal involves an agrement to pay more than $1 billion to settle some 800 cases alleging its Paxil antidepressant caused birth defects. For more on this story go to AboutLawsuits and Pharmalot.